In vivo modulation of the Parkinsonian phenotype by Nrf2

Chemical Compounds

• Neurotoxicity 84%
• Dopamine 47%
• Oxidative Stress 33%
• 3H-1,2-dithiole-3-thione 32%
• 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine 27%
• Dose 25%
• Antioxidant Agent 25%
• Inducer 19%
• Disorder 14%
• Protective 13%
• Pharmacological Metabolism 12%

Medicine & Life Sciences

• 4-phenyl-1,2,3,6-tetrahydropyridine 100%
• Thiones 46%
• Phenotype 40%
• Knockout Mice 18%
• Dopamine Plasma Membrane Transport Proteins 16%
• RTI 121 13%
• 1,2-dithiol-3-thione 12%
• Parkinson Disease 11%
• Oxidative Stress 9%
• 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine 8%
• Autoradiography 7%
• Neurodegenerative Diseases 5%
• Oral Administration 5%
• Dopamine 5%
• Rodentia 5%
• Transcription Factors 5%
• Animal Models 4%
• Enzymes 3%
• Brain 3%